secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K
Filed at:   2021-08-31T23:59:59+00:00
Accession:  0001493152-21-021692
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Interpace extends maturity on $7.5M notes from Ampersand and 1315 Capital to Sep 30, 2021
--------------------------------------------------------------------------------

- Maturity of $4.5M Ampersand Note and $3.0M 1315 Capital Note extended to September 30, 2021.
- Third amendments executed August 31, 2021; all other terms unchanged.
- Notes held by related parties that collectively own ~65.3% of common stock on as-converted basis.
- Security Agreement remains in full force and effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315221021692/0001493152-21-021692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315221021692/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-021692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer